Paul Noone
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
Papers in
- Pharmacology 35
- Antibiotics Pharmacokinetics and Efficacy 33
-
- Antibiotic Resistance in Bacteria 21
- Co-authors
- J Pattison (9 shared papers)Richard CB Slack (3 shared papers)R E Pounder (2 shared papers)Andrew Kirk (1 shared paper)Andrew Kenneth Burroughs (2 shared papers)W.B. Grubb (1 shared paper)Charles Greenfield (2 shared papers)Penny Smith (1 shared paper)
- Journals
- The Lancet (22 papers)Journal of Antimicrobial Chemotherapy (18 papers)Journal of Clinical Pathology (11 papers)Scandinavian Journal of Infectious Diseases (3 papers)Journal of Infection (3 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Paul Noone
77 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 121
- Molecular Medicine 290
- Clinical Biochemistry 233
- Infectious Diseases 632
- Applied Microbiology and Biotechnology 64
- Pharmacology 497
Countries citing papers authored by Paul Noone
This map shows the geographic impact of Paul Noone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Noone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Noone more than expected).
Fields of papers citing papers by Paul Noone
This network shows the impact of papers produced by Paul Noone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Noone. The network helps show where Paul Noone may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Noone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1974 | 305 | |
| 2 | 1984 | 179 | |
| 3 | 1974 | 167 | |
| 4 | 1982 | 138 | |
| 5 | 1977 | 133 | |
| 6 | 1985 | 84 | |
| 7 | 1980 | 81 | |
| 8 | 1983 | 70 | |
| 9 | 1971 | 60 | |
| 10 | 1981 | 57 | |
| 11 | 1980 | 55 | |
| 12 | 1977 | 54 | |
| 13 | 1988 | 52 | |
| 14 | 1986 | 49 | |
| 15 | 1974 | 48 | |
| 16 | 1989 | 42 | |
| 17 | 1971 | 41 | |
| 18 | The effective use of gentamicin in life-threatening sepsis. | 1974 | 37 |
| 19 | 1976 | 35 | |
| 20 | 2005 | 32 |
About Paul Noone
Paul Noone is a scholar working on Pharmacology, Molecular Medicine, Infectious Diseases, Clinical Biochemistry and Endocrinology, having authored 84 papers that have together received 2.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (33 papers), Antibiotic Resistance in Bacteria (21 papers), Antimicrobial Resistance in Staphylococcus (12 papers), Bacterial Identification and Susceptibility Testing (11 papers), Neutropenia and Cancer Infections (7 papers), Antibiotic Use and Resistance (6 papers), Mycobacterium research and diagnosis (5 papers) and Pneumonia and Respiratory Infections (4 papers). The work is most often cited by research in Molecular Medicine (290 citations), Clinical Biochemistry (233 citations), Infectious Diseases (632 citations), Applied Microbiology and Biotechnology (64 citations) and Pharmacology (497 citations). Paul Noone has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include J Pattison, Richard CB Slack, R E Pounder, Andrew Kirk, Andrew Kenneth Burroughs, W.B. Grubb, Charles Greenfield, Penny Smith, R P Walt and Elizabeth C. Wood. Their work appears in journals such as The Lancet, Journal of Antimicrobial Chemotherapy, Journal of Clinical Pathology, Scandinavian Journal of Infectious Diseases and Journal of Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.